$PVCT Provectus News Melanoma studies domin
Post# of 23081
Posted On: 10/07/2014 12:36:30 PM
$PVCT
Provectus News
Melanoma studies dominate ESMO
Tuesday October 7, 2014
An article appearing on Medical News Today notes that melanoma studies, such as the poster presentation on PV-10 entitled "Subgroup Efficacy in Patients Receiving Intralesional Rose Bengal to All Existing Melanoma in Phase II Study PV-10-MM-02", dominated both the Presidential Symposium and poster sessions at the European Society for Medical Oncology (ESMO) 2014 meeting.
The article is available at www.medicalnewstoday.com/articles/283527.php on the Medical News Today website.
Intralesional injections show promise for cutaneous melanoma
Tuesday October 7, 2014
An article appearing on eCancer News reports that the ESMO 2014 poster session ‘Melanoma and other skin tumours’, including a poster presentation on PV-10 efficacy, highlighted the emerging field of intralesional injections for cutaneous melanoma leading to tumour regression not only in the injected lesions, but also in 'bystander' lesions suggesting that the strategy is augmenting immune response.
The article is available at ecancer.org/news/6449-intralesional-injections-show-promise-for-cutaneous-melanoma.php on the eCancer News website.
Provectus News
Melanoma studies dominate ESMO
Tuesday October 7, 2014
An article appearing on Medical News Today notes that melanoma studies, such as the poster presentation on PV-10 entitled "Subgroup Efficacy in Patients Receiving Intralesional Rose Bengal to All Existing Melanoma in Phase II Study PV-10-MM-02", dominated both the Presidential Symposium and poster sessions at the European Society for Medical Oncology (ESMO) 2014 meeting.
The article is available at www.medicalnewstoday.com/articles/283527.php on the Medical News Today website.
Intralesional injections show promise for cutaneous melanoma
Tuesday October 7, 2014
An article appearing on eCancer News reports that the ESMO 2014 poster session ‘Melanoma and other skin tumours’, including a poster presentation on PV-10 efficacy, highlighted the emerging field of intralesional injections for cutaneous melanoma leading to tumour regression not only in the injected lesions, but also in 'bystander' lesions suggesting that the strategy is augmenting immune response.
The article is available at ecancer.org/news/6449-intralesional-injections-show-promise-for-cutaneous-melanoma.php on the eCancer News website.
(0)
(0)
I'm in it to win it!
NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'
NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'